| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Outsourcing > Outsourcing To India - Telesales |
|
Digg It - Outsourcing To India - Telesales
Introduction When the so-called outsourcing revolution began some ten years ago, nations like India were prime targets for companies and other enterprises that were attempting to reduce the costs of certain According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product functions that previously were undertaken in house. In this regard, a significant number of business enterprises and other organizations turned to India-based enterprises as outsourcing providers. A common ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in example of the type of outsourcing that was being undertaken within the nation of India was customer service and technical support. Many business enterprises turned to Indian providers because of the fact that empl lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. oyees in India are paid far less than what employees are paid in North American and most European nations. Thus, businesses were able to save a great deal of money by outsourcing different functions that once were here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ndertaken in house and at a significantly greater cost. Status of Outsourcing to India The movement towards and pace of outsourcing to India has slowed in recent years. Indeed, some companies that h d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ave outsourced to India have commenced recalling some of the functions that had been outsourced to India either back in house or to contract providers in other parts of the world. There are a number of reasons that ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc some businesses have started to move away from outsourcing to India in recent years. (One does need to keep in mind that India was the primary spot where a great deal of outsourcing functions were being undertaken easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi as the outsourcing trend really became a more steady flow in the 1990s and the early part of the 21st century. Some businesses have expressed concerns about the quality of services that they have been receiving fr nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically m outsourcing providers in the 21st century. This particularly has been the case when it comes to outsourced customer service and technical support functions. Despite the added costs that many times are experience and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ d when these functions are maintained in house, some companies actually have pulled these functions in house regardless of the expense to make sure that the highest quality standards when it comes to customer servic ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e and support is maintained. The net effect of movement out of India and the slowing down out outsourcing projects to that country is that India is becoming less of an outsourcing industry leader at this point in t ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ime. A number of other nations are hot on the heals of India when it comes to outsourcing efforts. Other Alternatives As suggested a moment ago, there are now alternatives to outsourcing to India. These o dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod tsourcing alternatives include: In North America and throughout Europe, there are now companies that have been set up with the intent of trying to compete with some of the inexpensive operations that are operating cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin in India. While these businesses cannot compete with India when it comes to the wages paid to employees, North American and European entities that are attempting to compete in the outsourcing marketplace are employ tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ing a broader range of technological advances that allows certain outsourced functions to be undertaken in a far more cost effective manner. When looking to Europe for outsourcing, some of the nations in the easter t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel n part of the continent have been particularly successful in meeting India head on. In some nations -- Romania, for example -- wages are lower than in other parts of Europe and North America. As a consequence, the ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust e are enterprises in these nations that have been able to compete fairly strongly with their Indian counterparts. The Future Businesses and other organizations will continue to use outsourcing services into y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products the future. In this regard, there will be a wider range of outsourcing alternatives available to businesses and other organizations in the future. More businesses and other organizations will consider domestic ou . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de tsourcing enterprises when they are in needed of outsourcing services. In addition, those companies and other entities that chose to outsource internationally will be considering countries above and beyond India. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip While India will still obtain a significant share of outsourced business into the foreseeable future, other countries will continue to take an ever increasing share of the outsourcing market during the coming decade tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Orthopedic Manufacturing - Technical School Talent Is Readily Available - The Benefits Run Both Ways What Average People Don't Know
|